Hadasit Bio (Israel) Management Performance Evaluation

HDST -- Israel Stock  

ILS 487.60  11.40  0.02%

Analysis of Hadasit Bio manpower and management performance can provide insight into Hadasit Bio stock performance. Also an employee sentiment is becoming a valuable factor that investors can use to determine the amount of risk that may be associated with Hadasit Bio Holdings future performance. Please also check Risk vs Return Analysis.

Hadasit Bio Management Effectiveness

The company has return on total asset (ROA) of (23.39) % which means that it has lost $23.39 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (27.5) % meaning that it generated substantial loss on money invested by shareholders.

Hadasit Bio Workforce Comparison

Hadasit Bio Holdings Ltd is rated below average in number of employees category among related companies. The total workforce of Biotechnology industry is currently estimated at about 1,215. Hadasit Bio adds roughly 5.0 in number of employees claiming only tiny portion of stocks in Biotechnology industry.

Hadasit Bio Profit Margins

The company has Profit Margin (PM) of 536.4 % which can be a sign that it executes well on its competitive strategies and has a good control over its expenditures. This is very large.

Hadasit Bio Stakeholders

Michel Habib CEO
Ophir Shahaf CEO
Moise Habib CEO
Baruch Halpert Chairman of the Board
Yoram Azulay Vice President - Finance
Yaakov Naparstek Director
Yigal Erlich Director
Oren Levy Director
Merav Kaye Director
Michal Sapir External Director
Asaf Reisfeld Director
Doron Nevo External Director
Yaron Kulas External Director
Ehud Kokia Director
Einat Zisman Director
Tamar Raz Director
Elka Nir External Director
Erez Meltzer Director
Rob Fink IR Contact Officer
Doron Cohen Internal Auditor

Hadasit Bio Leadership

Hadasit Bio Holdings Top Executives

  Michel Habib  CEO
  Ophir Shahaf  CEO

Hadasit Bio Tenure Analysis

Hadasit Bio Employment Tenure

Hadasit Bio employes about 5 people. The company is managed by 20 executives with total tenure of roughly 74 years, averanging almost 3.0 years of service per executive having 0.0 employee per reported executive.

Hadasit Bio Manpower Efficiency

Return on Hadasit Bio Manpower

Revenue Per Employee50 K
Revenue Per Executive12.5 K
Net Income Per Employee268 K
Net Income Per Executive67 K
Working Capital Per Employee11.8 M
Working Capital Per Executive3 M
Please also check Risk vs Return Analysis. Please also try Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Search macroaxis.com